All Competitors

Dual-target structure-based drug design that fuses two pocket-conditioned Bayesian flow distributions to generate 3D ligands binding both proteins.

Molecular glue degrader design model that jointly generates the glue molecule and the E3 ligase-target ternary complex from unbound monomers.

Unified drug design engine for protein-ligand structure prediction, binding affinity estimation, and compound generation from Isomorphic Labs.

De novo ligand design framework that generates protein binders and small molecules by inverting gradients through a differentiable docking model.

Sequence-only interaction model scoring protein-protein and protein-ligand pairs plus functional annotation across whole proteomes in seconds.

SE(3)-equivariant flow-matching model for pocket-aware 3D ligand generation, predicting binding affinity and confidence in the same network.

Structure-based drug design model generating 3D ligands in a protein pocket with interaction-guided flow matching and a learned atom-count predictor.

Blind protein-ligand docking model adding Ollivier-Ricci curvature descriptors and degree-aware message passing, predicting poses in 0.09 seconds.

Generative diffusion transformer for protein-ligand dynamics that produces trajectories, inpaints missing ligand atoms, and samples transition paths.

Structure-based drug design framework pairing pharmacophore-guided latent diffusion with training-free, pocket-aware evolutionary optimization.

Structure-based drug design model that generates 3D ligands inside a protein pocket by interpolating distribution parameters instead of samples.

Structure-based virtual screening model that scores ligands against apo and predicted pockets, lifting blind-apo EF1% on DUD-E from 11.75 to 37.19.

Protein-ligand docking model for high-throughput virtual screening, predicting binding poses with graph neural networks at low computational cost.

Structure-based drug design that schedules noise separately for 3D coordinates and 2D topology, reaching a 95.9% PoseBusters valid rate on CrossDock.

Pocket-conditioned 3D diffusion model for scaffold decoration, guided by evolutionary residue conservation and a protein-ligand interaction prior.

Protein binder design that inverts the frozen Boltz-1 all-atom predictor, targeting small molecules, nucleic acids, metals, and modified residues.

Binder motif prediction from receptor structure alone, mapping 14 functional-group types across a protein surface as reusable interaction profiles.

Structure-based molecule optimization that steers a Bayesian flow network with property gradients over 3D coordinates and atom types at once.

Pocket-conditioned 3D ligand generator trained on its own predicted conformations, closing the train-inference gap that degrades diffusion sampling.

Reprograms a frozen single-target diffusion model for dual-target drug design by composing SE(3)-equivariant messages across two aligned pockets.

Protein-ligand docking framework that picks the binding pocket by contrastive alignment, then refines the pose with bi-level iterative refinement.

Structure-based drug design that generates 3D ligands for a protein pocket entirely in the continuous parameter space of a Bayesian flow network.

Structure-based drug design diffusion model that re-extracts the essential binding subcomplex from a pocket at every step of 3D ligand generation.